West Paces Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.11K | Sell |
35
-4
| -10% | -$379 | ﹤0.01% | 515 |
|
|
2026
Q2 | $3.36K | Buy |
+39
| New | +$3.42K | ﹤0.01% | 506 |
|
|
2025
Q2 | – | Sell |
-12
| Closed | -$1.36K | – | 576 |
|
|
2025
Q1 | $1.36K | Hold |
12
| – | – | ﹤0.01% | 469 |
|
|
2024
Q4 | $1.27K | Hold |
12
| – | – | ﹤0.01% | 472 |
|
|
2024
Q3 | $1.3K | Hold |
12
| – | – | ﹤0.01% | 463 |
|
|
2024
Q2 | $1.3K | Hold |
12
| – | – | ﹤0.01% | 475 |
|
|
2024
Q1 | $1.58K | Hold |
12
| – | – | ﹤0.01% | 475 |
|
|
2023
Q4 | $1.46K | Hold |
12
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $1.35K | Hold |
12
| – | – | ﹤0.01% | 446 |
|
|
2023
Q2 | $1.75K | Hold |
12
| – | – | ﹤0.01% | 458 |
|
|
2023
Q1 | $1.55K | Hold |
12
| – | – | ﹤0.01% | 484 |
|
|
2022
Q4 | $1.53K | Hold |
12
| – | – | ﹤0.01% | 451 |
|
|
2022
Q3 | $1.26K | Sell |
12
-18
| -60% | -$1.98K | ﹤0.01% | 456 |
|
|
2022
Q2 | $3.15K | Sell |
30
-2
| -6% | -$237 | ﹤0.01% | 451 |
|
|
2022
Q1 | $4.09K | Buy |
32
+13
| +68% | +$1.57K | ﹤0.01% | 427 |
|
|
2021
Q4 | $2.29K | Sell |
19
-51
| -73% | -$6.68K | ﹤0.01% | 517 |
|
|
2021
Q3 | $10K | Sell |
70
-7
| -9% | -$1.03K | ﹤0.01% | 359 |
|
|
2021
Q2 | $12.1K | Buy |
77
+7
| +10% | +$1.13K | ﹤0.01% | 343 |
|
|
2021
Q1 | $10.9K | Hold |
70
| – | – | ﹤0.01% | 327 |
|
|
2020
Q4 | $10.5K | Sell |
70
-18
| -20% | -$2.54K | ﹤0.01% | 306 |
|
|
2020
Q3 | $11.6K | Hold |
88
| – | – | 0.01% | 287 |
|
|
2020
Q2 | $10.1K | Hold |
88
| – | – | 0.01% | 309 |
|
|
2020
Q1 | $8.59K | Hold |
88
| – | – | 0.01% | 322 |
|
|
2019
Q4 | $12.7K | Hold |
88
| – | – | 0.01% | 323 |
|
|
2019
Q3 | $11.7K | Hold |
88
| – | – | 0.01% | 311 |
|
|
2019
Q2 | $10K | Hold |
88
| – | – | 0.01% | 313 |
|
|
2019
Q1 | $10.9K | Hold |
88
| – | – | 0.01% | 309 |
|
|
2018
Q4 | $8.82K | Hold |
88
| – | – | 0.01% | 324 |
|
|
2018
Q3 | $11.2K | Hold |
88
| – | – | 0.01% | 314 |
|
|
2018
Q2 | $9.47K | Hold |
88
| – | – | 0.01% | 334 |
|
|
2018
Q1 | $9.27K | Hold |
88
| – | – | 0.01% | 325 |
|
|
2017
Q4 | $10.3K | Hold |
88
| – | – | 0.01% | 334 |
|
|
2017
Q3 | $10K | Hold |
88
| – | – | 0.01% | 333 |
|
|
2017
Q2 | $10.9K | Sell |
88
-380
| -81% | -$45.1K | 0.01% | 321 |
|
|
2017
Q1 | $55.4K | Sell |
468
-573
| -55% | -$64.9K | 0.04% | 165 |
|
|
2016
Q4 | $104K | Buy |
+1,041
| New | +$112K | 0.1% | 143 |
|
Other funds holding ZBH
West Paces Advisors's ZBH Position: Q3 2026 in Review
West Paces Advisors reduced its Zimmer Biomet (ZBH) stake by 10% in Q3 2026, selling an estimated $379 and leaving 35 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #515.
West Paces Advisors first reported a position in ZBH in Q4 2016 and has held it in 36 quarters since. The position peaked at $104K in Q4 2016. 198 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.
- West Paces Advisors held 35 shares of Zimmer Biomet worth $3.11K as of Q3 2026.
- West Paces Advisors sold 4 Zimmer Biomet shares in Q3 2026, an estimated $379.
- Zimmer Biomet made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #515 holding.
- West Paces Advisors first reported a position in Zimmer Biomet in Q4 2016 and has held it in 36 quarters since.
- West Paces Advisors's Zimmer Biomet position peaked at $104K in Q4 2016.
- 198 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.
Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.